chitosan has been researched along with Bancroftian Elephantiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramaniyan, M; Perumal, K; Santhanam, M; Vinayagam, V | 1 |
| Kaliraj, P; Malathi, B; Mona, S; Thiyagarajan, D | 1 |
2 other study(ies) available for chitosan and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Immunomodulatory effects of chitosan nanoparticles as vaccine delivery agent against lymphatic filariasis through mucosal immunization.
Topics: Animals; Brugia malayi; Chitosan; Elephantiasis, Filarial; Immunization; Mice; Mice, Inbred BALB C; Nanoparticles; Vaccination; Vaccines | 2022 |
Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.
Topics: Animals; Antigens, Helminth; Brugia malayi; Chitosan; Elephantiasis, Filarial; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Nanospheres; Spectroscopy, Fourier Transform Infrared; Thioredoxins; Vaccines | 2015 |